Instadose Pharma Corp
OTC:INSD
Income Statement
Earnings Waterfall
Instadose Pharma Corp
Income Statement
Instadose Pharma Corp
| Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Operating Income |
(0)
N/A
|
(0)
-13%
|
(0)
-149%
|
(0)
-67%
|
(0)
-282%
|
(2)
-241%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-13%
|
(0)
-149%
|
(0)
-67%
|
(0)
-282%
|
(2)
-247%
|
|
| Net Income | |||||||
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-13%
|
(0)
-149%
|
(0)
-67%
|
(0)
-282%
|
(2)
-247%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|